Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma

被引：0
|
作者：
DeLiberty, Jonathan M.
Stalnecker, Clint A.
Drizyte-Miller, Kristina
Schechter, Elyse G.
Pieper, Noah L.
Yang, Runying
Der, Channing J.
Cox, Adrienne D.
Bryant, Kirsten L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4851
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4851
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
    Principe, Daniel R.
    Underwood, Patrick W.
    Korc, Murray
    Trevino, Jose G.
    Munshi, Hidayatullah G.
    Rana, Ajay
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition
    Fey, Sigrid K.
    Najumudeen, Arafath K.
    Watt, Dale M.
    Millett, Laura M.
    Ford, Catriona A.
    Gilroy, Kathryn
    Simpson, Rosalin J.
    Mclay, Kathy
    Upstill-Goddard, Rosanna
    Chang, David
    Clark, William
    Nixon, Colin
    Birch, Joanna L.
    Barry, Simon T.
    Morton, Jennifer P.
    Campbell, Andrew D.
    Sansom, Owen J.
    CANCER RESEARCH, 2025, 85 (02) : 251 - 262
  • [23] Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?
    Delma, Mohamed Islam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [24] HSF1 inhibition induces pancreatic ductal adenocarcinoma autophagy through JNK
    Ghai, Shruti
    Young, Alex
    Su, Kuo-Hui
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition
    X Li
    D Roife
    Y Kang
    B Dai
    M Pratt
    J B Fleming
    Oncogene, 2016, 35 : 4881 - 4890
  • [26] Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition
    Li, X.
    Roife, D.
    Kang, Y.
    Dai, B.
    Pratt, M.
    Fleming, J. B.
    ONCOGENE, 2016, 35 (37) : 4881 - 4890
  • [27] The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
    Kudo, Daisuke
    Suto, Akiko
    Hakamada, Kenichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
  • [28] EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma
    Liu, Fuyuan
    Wu, Weikang
    Cao, Weiwei
    Feng, Liangyong
    Yuan, Juzheng
    Ren, Zhuohui
    Dai, Niu
    Wang, Xudan
    Li, Xiao
    Yue, Shuqiang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (07):
  • [29] Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
    Fukuda, Junki
    Kosuge, Shinya
    Satoh, Yusuke
    Sekiya, Sho
    Yamamura, Ryodai
    Ooshio, Takako
    Hirata, Taiga
    Sato, Reo
    Hatanaka, Kanako C.
    Mitsuhashi, Tomoko
    Nakamura, Toru
    Matsuno, Yoshihiro
    Hatanaka, Yutaka
    Hirano, Satoshi
    Sonoshita, Masahiro
    CANCER SCIENCE, 2024, 115 (04) : 1333 - 1345
  • [30] Dual inhibition of glycolysis and autophagy as a therapeutic strategy in the treatment of Ehrlich ascites carcinoma
    Mansour, Mohammed A.
    Ibrahim, Wafaa M.
    Salama, Mona M.
    Salama, Afrah F.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2020, 34 (07)
12345